Table of Contents
Table of Contents
Preface
Chapter 1. Diagnosis, Prognosis and Genetic Features of Mantle Cell Lymphoma
Haipeng Shao, Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Chapter 2. Mantle Cell Lymphoma: Current Treatment Strategies in the Era of Targeted Agents
Muhammad Omer Jamil, Maira Rizwan, Amitkumar Mehta, Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Chapter 3. Targeted Drugs in the Treatment of Mantle Cell Lymphoma
Piotr Smolewski, Magdalena Witkowska, Tadeusz Robak, Department of Experimental Hematology, and Department of Hematology, Medical University of Lodz, Poland
Chapter 4. Emerging Role of Novel Agents in the Treatment of Mantle Cell Lymphoma
Bridgette A. Kanz, Mahsa S. Talbott, Nishitha M. Reddy, Department of Pharmacology, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
Chapter 5. Current Place of Proteasome Inhibitors in the Treatment of Mantle Cell Lymphoma
Panagiotis J. Vlachostergios, Rajeev L. Balmiki, Department of Internal Medicine, Lutheran Medical Center, Brooklyn, NY, USA
Index
